Stock Rich List
#10054 on the rich list of 14,452 insiders

John A. Stalfort III

Director at Taysha Gene Therapies; Director at Verrica Pharmaceuticals; Director at Acumen Pharmaceuticals. Based in Newton, Massachusetts.

$8.4M
in disclosed stock, −$448K (−5.09%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
10054th of 14,452
Companies held
3
Largest holding
TSHA, 93.0% of total
Latest SEC filing
Jun 3, 2026

What the $8.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Taysha Gene Therapies TSHA
Common Stock
Directly1,176,559$3.77$4.4M53.1%Form 4, Jun 1, 2026
Taysha Gene Therapies TSHA
Common Stock
Through John A. Stalfort III 2018 Irrevocable Trust884,290$3.77$3.3M39.9%Form 4, Jun 1, 2026
Verrica Pharmaceuticals VRCA
Common Stock
Directly187,380
split-adjusted
$2.89$541K6.5%Form 4, Nov 26, 2024
Acumen Pharmaceuticals ABOS
Common Stock
Directly220,624$0.19$43K0.5%Form 4, Jun 3, 2026

Share counts are the amounts John A. Stalfort III reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
10051Sundeep Agrawal
Director, BlossomHill Therapeutics. San Diego, CA
$8.4M−$106K (−1.25%)
10052Stephen J. Hagge
Director, CF Industries Holdings. Tampa, FL
$8.4M+$103K (+1.25%)
10053Russell Wayne Ford
Chief Executive Officer, StandardAero. Scottsdale, AZ
$8.4M−$108K (−1.28%)
10054John A. Stalfort III
Director, Taysha Gene Therapies. Newton, MA
$8.4M−$448K (−5.09%)
10055Tony Kim
Insider, BlackRock Science and Technology Term Trust. New York, NY
$8.4M−$230K (−2.68%)
10056Andrew Joseph Bestwick
CHIEF TECHNOLOGY OFFICER, Rigetti Computing. Berkeley, CA
$8.4M−$280K (−3.24%)
10057John T. Raymond
Director, Plains GP Holdings. Houston, TX
$8.4M−$42K (−0.50%)

Other Taysha Gene Therapies insiders

All TSHA insiders

Questions

How much stock does John A. Stalfort III own?

John A. Stalfort III holds $8,352,639 in listed stock based on SEC filings and current prices, mostly Taysha Gene Therapies (TSHA). That ranks 10054th on the Stock Rich List.

Is this John A. Stalfort III's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.